Google
Trusted Resources: People & Places
Healthcare providers, researchers, and advocates
Sandeep Soni, MD
Researcher Executive Director
CRISPR Therapeutics, Inc.
610 Main Street
Cambridge, Massachusetts, United States
Sandeep Soni, MD, is the Executive Director at CRISPR Therapeutics, Inc. His expertise includes bone marrow transplantation (HSCT), cellular therapies and gene therapy for malignant and non-malignant blood disorders and clinical development of programs. He is also an expert of lentiviral vectors, Crispr- Cas9 gene editing, stem cell transplant, T-cell therapies and regulatory/safety aspects of gene-therapies.
Areas of Interest-
– Cellular Therapy
– Gene Therapy
– Stem Cell Transplant
– Sickle Cell Disease
– Thalassemia
– Reduced Intensity Conditioning
Clinical Focus-
– Hematology/Oncology
– Stem Cell Transplant and Gene Therapy
+myBinderRelated Content
-
Sickle Cell Pulmonary Clinic, Connecticut Children’s Medical CenterConnecticut Children’s is one of the f...
-
Patients With Sickle Cell Disease may Have Lower Risk for C. DifficileFindings from a retrospective cohort stu...
-
Hope for SCDHope for SCD strives to bridge the gap b...
-
A Developmental Examination of Pain Among Youth with Sickle Cell DiseaseIntroduction: Sickle cell disease (SCD)...
-
Barbara Harrison, MSBarbara Harrison is currently an Assista...
-
Howard Woolley, MASHoward Woolley is a philanthropist with ...
-
FDA Approves Novel Treatment to Target Abnormality in Sickle Cell DiseaseToday, the U.S. Food and Drug Administra...
